首页 正文

Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab

{{output}}
Background: Systemic reactions (SR) to venom immunotherapy (VIT) are rare but may occur, with a rate significantly higher for honeybee than for vespid VIT. In patients with repeated SRs to VIT it is difficult to reach the mainten... ...